SANACORP PHARMAHOLDING AG. Interim Financial Report

Size: px
Start display at page:

Download "SANACORP PHARMAHOLDING AG. Interim Financial Report"

Transcription

1 SANACORP PHARMAHOLDING AG Interim Financial Report for the period 1 January to 30 September 2012

2 Interim Financial Report 1 January to 30 September 2012 Sanacorp Pharmaholding AG 2 Interim Management Report Dear Shareholder, this interim report provides information on the business performance of Sanacorp Pharmaholding AG for the period 1. January through 30 September As Sanacorp Pharmaholding AG is a pure holding company, its net income depends almost entirely on the amount of income received from long-term equity investments. At the present time, the Company only holds one equity investment an interest in Sanastera S.p.A., Bologna, Italy. In turn, Sanastera S.p.A. holds equity investments in pharmaceutical wholesale companies in Germany, France and Belgium. The dividends paid by Sanastera S.p.A. to Sanacorp Pharmaholding AG are dependent on the profits generated by these operating companies. This interim report therefore not only gives an overview of the business performance of Sanacorp Pharmaholding AG, but also provides information on the performance of the operating companies as well as the Sanastera Group for the period from 1 January 2012 to 30 September Sanastera S.p.A. has already paid a dividend to the Company s two shareholders during the second quarter of In accordance with the resolution of the general meeting, the distribution amounted to a total of 19,450 thousand. Sanacorp Pharmaholding AG received income from long-term equity investments amounting to 9,725 thousand in line with its shareholding of 50 %. This equated to an increase of 75 thousand over the dividend income received by Sanacorp Pharmaholding AG in the first half of 2011 ( 9,650 thousand). The operating costs of Sanacorp Pharmaholding AG for the first nine months were also completely in line with the expectations of the Management Board. Due to lower expenses and increased income from equity investments, the result from ordinary activities of Sanacorp Pharmaholding AG improved during the period from 1 January 2012 to 30 September 2012, rising from 9,026 thousand in the prior-year period to 9,219 thousand in the current year period. The business performance of the pharmaceutical wholesale companies who work for the German/French joint venture Sanastera S.p.A. can also be regarded as predominantly positive for the nine months. Although Sanacorp Pharmahandel GmbH, which operates in Germany, suffered a slight decline in sales, the package of measures that had been introduced and the new remuneration structure for pharmaceutical wholesalers led to a noticeable stabilisation of profitability. It was possible, particularly due to the increase in sales recorded in France, to exceed the profit performance expected by the management of CERP Rouen SAS at the beginning of the year. General information Sanacorp Pharmaholding AG is a listed financial holding company with a co-operative backdrop; its main shareholder is Sanacorp eg Pharmazeutische Großhandlung. Sanacorp Pharmaholding AG holds a 50 % equity investment in Sanastera S.p.A.; this company is domiciled in Bologna, Italy. The joint holding company Sanastera S.p.A. unites pharmacist-controlled pharmaceutical wholesalers in Germany, France and Belgium under one umbrella. The operating companies that are grouped under this Italian holding company, Sanacorp Pharmahandel GmbH in Germany, CERP Rouen SAS in France and CERP SA in Belgium, supply more than 16,000 pharmacies with medicines and healthcare products in these countries.

3 Interim Financial Report 1 January to 30 September 2012 Sanacorp Pharmaholding AG 3 Projects and Events In the summer, Sanacorp Pharmahandel GmbH, together with participating pharmacies, was delighted to receive two awards from two independent institutions for its mea meine Apotheke cooperation program. Top marks were received for service and advice. The cooperation was formed by Sanacorp in Sanacorp continues to support the cooperation participants with training, advertising and marketing campaigns, continuous optimisation of over-the-counter and behind-the-counter product selection and various tried and tested additional services. The initial feedback on the new individual medicine dosage system for patients in smaller and medium-sized care homes or nursing homes, developed by Sanacorp Pharmahandel GmbH and its French partner, is also pleasing. In addition to its function as a pharmaceutical wholesaler supplying the full range of medicines to pharmacies, Sanacorp Pharmahandel GmbH will in future be significantly expanding its offering to the pharmaceutical industry. For this purpose, as an initial step, a subsidiary has been set up by the Company. This subsidiary will take over and expand the manufacturer logistical services which are occasionally now already being offered by Sanacorp Pharmahandel GmbH. A similar model is already being implemented in France by Sanacorp s French partner. As a result of the pleasing sales performance and in order to provide the best possible supply to the pharmacies, CERP Rouen SAS is building a new branch near Nantes and expanding capacities at its existing Limoges site. Once the new branch in the Nantes region has been opened in the first quarter of the 2013 financial year, the Company will close its current sites in Nantes and St Naziere. Other investments were made to improve cooling technology and warehouse logistics. As part of the complete overhaul of the Internet offering of the Sanacorp Group of companies, a separate website was set up for the shareholders of Sanacorp Pharmaholding AG. At interested parties can from now on find all the information relating to Sanacorp Pharmaholding AG in a clearly structured format. An expanded service offering is available to customers of Sanacorp Pharmahandel GmbH at Results of Operations During the period from 1 January 2012 to 30 September 2012, Sanacorp Pharmaholding AG received income from long-term equity investments of 9,725 thousand. This equated to an increase of 75 thousand over the prior year comparative period. As in the previous year, income from long-term equity investments resulted exclusively from the dividend share the company received from Sanastera S.p.A. in the second quarter of 2012, which was for the previous financial year. In addition to the higher income from equity investments, a slight reduction in costs and improvement in net interest income also contributed to an increase in the result from ordinary activities. For the time period from 1 January 2012 to 30 September 2012, the result from ordinary activities amounted to 9,219 thousand, compared to 9,026 thousand for the comparative period. No income taxes were incurred during the reporting period because the only income received was income from equity investments. Net income for the period thus also equated to 9,219 thousand. In contrast to the market as a whole (+0.40 %), sales generated by Sanacorp Pharmahandel GmbH in Germany in the period from 1 January 2012 to 30 September 2012 declined slightly. At 2,715,619 thousand, sales were 1.14 % lower than in the corresponding period of the previous year ( 2,746,975). Following the change in the Sanacorp pricing model at the start of financial year 2012, sales reported for the current reporting period also include fees that have sales characteristics. These fees had previously been recognised under other operating income. The new remuneration model in force since the start of the year, as well as the change in reporting, led to an improvement in the Company s gross margin when compared to the prior year period. It rose from 5.43 % to 6.33 %. Excluding the reclassification, the gross margin for the first nine months of 2012 was 5.93 %. In addition to the stabilisation of the core business, the first positive effects of the optimisation programme which had commenced in the previous year as well as a slight improvement in the financial result contributed to the positive performance of the result from ordinary activities of the Sanacorp Pharmahandel GmbH sub-group during the reporting period. It rose from 845 thousand to 18,467 thousand. Net income for the period from 1 January 2012 to 30 September 2012 amounted to 11,836 thousand. For the comparative period of the previous year, a loss for the period of 136 thousand had been reported. The CERP Rouen SAS Group, which operates in France and Belgium, was also able to carry its successful performance from the previous quarters into the third quarter of financial year At 2,760,664 thousand, sales generated by the group of companies were 1.03 % higher than in the corresponding prior year period. In the French market

4 Interim Financial Report 1 January to 30 September 2012 Sanacorp Pharmaholding AG 4 in particular it was possible to markedly exceed market performance. The pleasing sales performance, together with an internal savings program, was fully able to compensate for the effects of the new pricing regulations that have applied in France since the start of the year. The gross margin improved and rose from 4.37 % to 4.45 %. The result from ordinary activities (under IFRS) rose to 22,725 thousand in the reporting period and was therefore 1,924 thousand more than in the corresponding prior-year period. Net income for the period from 1 January 2012 to 30 September 2012 amounted to 14,343 thousand (previous year: 13,285 thousand). Net assets During the third quarter of 2012, Sanacorp Pharmaholding AG performed an offset of the Group financing clearing accounts. The Company s current assets reduced as a result. At the 30 September 2012 reporting date, total assets of Sanacorp Pharmaholding AG amounted to 330,927 thousand. At the prior year balance sheet date, they were 339,820 thousand. Total assets of Sanacorp Pharmahandel GmbH as at 30 September 2012 amounted to 700,809 thousand and therefore exceeded the amount at the previous year s balance sheet date by 72,631 thousand. In addition to the stocking up of merchandise, the reason for the increase was the complete transfer back of receivables that had been transferred out under a factoring scheme. As a result, trade receivables increased significantly. Financial Position Cash Pooling at Group financing level has a significant impact on the cash flows of Sanacorp Pharmaholding AG. As already explained, the existing clearing accounts were offset during the third quarter. This resulted in a reduction in liabilities to affiliated companies. Compared to the position at the previous year s balance sheet date, Sanacorp Pharmahandel GmbH had markedly expanded its liabilities to suppliers at the 30 September 2012 reporting date. The resulting liquidity was used to transfer back the existing factoring scheme in its entirety as well as to reduce bank borrowing. The reduction in the securities portfolio of the CERP Rouen SAS Group was mainly utilised to reduce bank borrowing. Employee Development Sanacorp Pharmaholding AG did not employ any employees of its own during the reporting period. At the 30 September 2012 reporting date, the operating companies of the Sanastera Group employed a total full-time equivalent of 4,443 employees. This represents a reduction in employee numbers of 224 (4,667) compared to the prior year reporting date. The decrease arose due to personnel reductions in all the national operating companies. The investment in the new construction of the branch near Nantes mentioned above and the investment in the modernisation of existing sites resulted in an increase in fixed assets in the balance sheet of CERP Rouen SAS. Above all, a reduced securities portfolio led to a decrease in current assets. At the 30 September 2012 reporting date, total assets amounting to 922,697 thousand were reported in the balance sheet of CERP Rouen SAS, which represents a reduction from the position at the previous year s balance sheet date ( 980,592 thousand).

5 Interim Financial Report 1 January to 30 September 2012 Sanacorp Pharmaholding AG 5 Sanastera S.p.A.-Group Pro-forma income statement of the Sanastera-Group (in accordance with IFRS): 1 JAN 30 SEP 12 1 JAN 30 SEP 11 THOUS. THOUS. Sales revenue 5,476,283 5,479,374 Other operating income 52,615 58,752 Cost of materials 5,181,723 5,210,919 Gross profit 347, ,207 Personal expenses 169, ,827 Amortization and depreciation expense 22,514 19,958 Other operating expenses 113, ,391 Operating profit 41,323 25,031 Net financial income 1,357 2,932 Profit before income tax 39,966 22,099 Income taxes 14,196 8,039 Net profit for the period 25,770 14,060 Sales generated by the Sanastera Group national operating companies totalled 5,476,283 thousand during the period from 1 January 2012 to 30 September This equates to a slight reduction of 0.06 % on the prior-year period. While sales in France increased, there was a small reduction in sales in the German market. The sales growth in the French market as well as the fundamental reorganisation of the pharmaceutical wholesale remuneration model in Germany led to an improvement in gross profit. The gross profit of the Sanastera Group rose from 327,207 thousand to 347,175 thousand. The gross margin was 5.38 %. In addition to the stabilisation of the core business, the optimisation and profit safeguarding measures pursued by the national operating companies also contributed to the fact that it is possible to report a positive performance overall for the Sanastera Group for this first part of financial year However, it must be noted that the situation in the German market remains tense. Even if the internal restructuring and cost savings programs that have been introduced have the desired effect, they can only compensate for part of the losses caused by the Gesetz zur Neuordnung des Arzneimittelmarktes (AMNOG German Pharmaceutical Restructuring Act). The result from ordinary activities achieved by the Sanastera Group during the period from 1 January 2012 to 30 September 2012 amounted to 39,966 thousand and was therefore 17,867 thousand more than in the corresponding prior-year period. An improvement in net interest income also contributed to this. Net income for the same period was 25,770 thousand, compared to 14,060 thousand in the comparative period. Pro-forma cash-flow statement of the Sanastera-Group (in accordance with IFRS): 1 JAN 30 SEP 12 1 JAN 30 SEP 11 THOUS. THOUS. Cash flows from operating activities + 32, ,679 Cash flows from investing activities 19,612 14,813 Cash flows from financing activities 38,132 9,337 The cash inflow from operating activities of 32,775 thousand was mainly affected by the repayment of the factoring scheme and higher liabilities to suppliers. Cash outflow from investing activities was 19,612 thousand. Loan repayments resulted in a cash outflow from financing activities of 38,132 thousand.

6 Interim Financial Report 1 January to 30 September 2012 Sanacorp Pharmaholding AG 6 Report on Post-Balance Sheet Events There were no important events after the end of the reporting period up to the time of the preparation and signing of this interim management report that significantly affect the financial position, cash flows and profit or loss of Sanacorp Pharmaholding AG. Risk and Opportunities Report The explanations concerning the risk profile of Sanacorp Pharmaholding AG contained in the management report of the 2011 annual financial statements remain unchanged and continue to apply. As of today, there are no indications of any risks that either individually or collectively jeopardise the continuation as a going concern of Sanacorp Pharmaholding AG, Sanastera S.p.A, or the companies operating at a national level. Sanacorp Pharmaholding AG is indirectly affected by the operating performance of the pharmaceutical wholesale companies in Germany, France and Belgium through its equity investment in Sanastera S.p.A. Intervention in the health system by respective governments is the main risk in the pharmaceutical market. Among other things, historical and future financing of welfare systems is important in this context, as are the developments in health care costs. Basically one has to assume that an economic slowdown will lead to a rise in unemployment and the associated burden on social security systems. The Company does not assume that the fundamental reorganisation of the financing of health services in Germany, which is once again under discussion, will take place during the current legislative period. At the same time, further short-term cost measures by the legislator remain a possibility. Like the Gesetz zur Neuordung des Arzneimittelmarktes (AMNOG German Pharmaceutical Restructuring Act) or the new regulations passed by the French government at the end of December 2011, these can have an adverse direct or indirect effect on pharmaceutical wholesalers in the respective markets. Outlook In view of the performance to date of Sanacorp Pharmaholding AG, the Management Board is confident that the Company will also be able to report a slight increase in the result from ordinary activities for the full year. Moreover, based on this forecast, the Management Board expects to once again be able to pay a dividend to the shareholders of Sanacorp Pharmaholding AG amounting to 0.94 per ordinary share and 0.99 per preference share. During financial year 2012, both Sanacorp Pharmahandel GmbH and CERP Rouen SAS each made distributions of 10,000 thousand from the net retained profits of financial year 2011 to Sanastera S.p.A. As a result of these distributions, Sanastera S.p.A. will also be able to pay a dividend to the shareholders of the Company for financial year If this is the case, Sanacorp Pharmaholding AG should also in financial year 2013 receive income from equity investments that equates to the previous year s level. Assuming that the performance in the final quarter of the current financial year is in line with expectations, the Management Board of Sanacorp Pharmaholding AG expects that the CERP Rouen SAS Group will be able to slightly improve its result for financial year 2012 from the previous year. In view of the stabilisation of the core business observed in Germany, Sanacorp Pharmahandel GmbH will also generate a result in financial year 2012 which will allow a distribution to be made to Sanastera S.p.A. at the prior-year level. Apart from changes in the legal framework, future developments concerning the level of competition have the most impact on profitability. The fundamental changes in the remuneration of pharmaceutical wholesalers in Germany, introduced on 1 January 2012 with the second stage of the AMNOG, led to an alignment of the pricing models of all market participants. Furthermore, AMNOG sets a legal limit for all market participants on the amount of discount that may be granted because the fixed remuneration is not discountable. The new remuneration models may also contribute to improving the competitiveness of German wholesalers in relation to the direct selling by the pharmaceutical manufacturers.

7 Interim Financial Report 1 January to 30 September 2012 Sanacorp Pharmaholding AG 7 Balance Sheet of Sanacorp Pharmaholding AG ASSETS 30 SEP DEC 2011 THOUS. THOUS. THOUS. Fixed Assets Financial assets 330, ,221 Total fixed assets 330, ,221 Current assets Receivables and other asset Receivables from other long-term investees and investors Other assets 701 8,899 Total current assets 701 9,598 Prepaid expenses 5 1 Total assets 330, ,820 EQUITY AND LIABILITIES 30 SEP DEC 2011 THOUS. THOUS. Equity Subscribed capital 24,638 24,638 Capital reserve 98,934 98,934 Other revenue reserves 186, ,500 Net retained profit 13,196 11,808 Total equity 323, ,880 Total provision Liabilities Trade payables 1 Liabilities to affiliated companies 7,243 17,474 Other liabilities 52 Total liabilities 7,295 17,475 Total equity and liabilities 330, ,820

8 Interim Financial Report 1 January to 30 September 2012 Sanacorp Pharmaholding AG 8 Income Statement of Sanacorp Pharmaholding AG 1 JAN SEP 12 1 JAN SEP 11 THOUS. THOUS. Other operating income Gross profit Personnel expenses Other operating expenses Operating profit Income from long-term equity investments 9,725 9,650 Other interest and similar income Interest and similar expenses Profit from ordinary activities 9,219 9,026 Income taxes Net profit for the period 9,219 9,026

9 Interim Financial Report 1 January to 30 September 2012 Sanacorp Pharmaholding AG 9 Notes and other disclosures Accounting Policies The accounting policies applied in this 9-month interim report are the same as those applied in the last annual financial statements. The interim financial statements were prepared in accordance with the provisions of the Handelsgesetzbuch (HGB German Commercial Code) and the Aktiengesetz (AktG German Stock Corporation Act) as amended at the time of the preparation of the half-yearly financial statements. The present interim report was reviewed by the Audit Committee of the Supervisory Board and discussed with the Management Board on 12 November The interim report was not subject to a separate external audit and respectively. The closing price at the end of the reporting period was Other Disclosures At 30 September 2012, the shareholding of members of the Supervisory Board had reduced to 1,794 Sanacorp Pharmaholding AG preference shares. The reason for the reduction was Jürgen Funke s retirement from the Supervisory Board. The shareholding of the members of the Management Board was unchanged from the last balance sheet date; it amounted to 91 preference shares of the Company. Sanacorp Shares Sanacorp Pharmaholding AG shares continued their sideways movement during the third quarter of financial year During the period from 1 January 2012 to 30 September 2012, the highest and lowest share prices were 125 % 120 % 115 % 110 % 105 % 100 % 95 % 90 % 1 Jan Sep 2012 Sanacorp CDAX SDAX GSX Sanacorp share vs. CDAX, SDAX, GSX in % (1 Jan 30 Sep 2012)

10 Interim Financial Report 1 January to 30 September 2012 Sanacorp Pharmaholding AG 10 Significant Business Transactions between Related Parties Related party disclosures 1 JAN SEP 12 1 JAN SEP 11 THOUS. THOUS. Revenue and income from services, loans and amounts charged on Purchase of services, loans and amounts charged on 164 1,845 Receivables from related entities 702 9,644 Liabilities to related entities 7,296 17,399 Relationship with the Management Board Revenue 1, Receivables from the Management Board 127 Relationship with the Supervisory Board Revenue 11,721 11,581 Receivables from the Supervisory Board 1,152 1,138 Relationship with other related parties Revenue 1,705 1,635 Receivables from other related parties Remuneration of managers in key positions comprises the remuneration of the active Management Board and the Supervisory Board. This did not change materially from the last annual financial statements. The disclosures on sales to and receivables from the Management Board, the Supervisory Board and other related parties relate to the operating company in Germany. Sanastera S.p.A. distributed a dividend of 9,725 thousand to Sanacorp Pharmaholding AG during the reporting period. Planegg, 14 November 2012 Sanacorp Pharmaholding Aktiengesellschaft The Management Board Dr. Herbert Lang Klaus Edelmann Karin Kaufmann Erwin Zattler

11 Upcoming events 28 March 2013 Release of the financial report for the financial year May 2013 Release of the interim report for the period 1 January to 31 March June 2013 Annual General Meeting for the financial year 2012 Sanacorp Pharmaholding AG Hauptverwaltung Semmelweisstraße Planegg Germany Tel Fax

Letter from the Management Board 3. Key Financial Figures 4. Management Report 5. Consolidated Income Statement (IFRS) 9

Letter from the Management Board 3. Key Financial Figures 4. Management Report 5. Consolidated Income Statement (IFRS) 9 3-Months Report 2015 Content Letter from the Management Board 3 Key Financial Figures 4 Management Report 5 Consolidated Income Statement (IFRS) 9 Consolidated Statement of Comprehensive Income (IFRS)

More information

CONSOLIDATED INTERIM FINANCIAL STATEMENTS

CONSOLIDATED INTERIM FINANCIAL STATEMENTS CONSOLIDATED INTERIM FINANCIAL STATEMENTS AND GROUP INTERIM MANAGEMENT REPORT SECOND QUARTER OF 2008 JUNE 30, 2008 FRANCONOFURT AG FRANKFURT AM MAIN FRANCONOFURT AG, FRANKFURT AM MAIN CONSOLIDATED INTERIM

More information

Overview of the key figures for the first half of the year

Overview of the key figures for the first half of the year Half-Year Report 2015 Q2 Revenues increase in the first half of the year by 23% EBIT increased by 1.5 million euros compared to the previous year Order book is growing Overall annual forecast remains unchanged

More information

2015 Quarterly Report II

2015 Quarterly Report II 2015 Quarterly Report II 2 Key data Eckert & Ziegler 01 06/2015 01 06/2014 Change Sales million 69.0 61.9 + 11 % Return on revenue before tax % 16 % 9 % + 87 % EBITDA million 15.6 9.7 + 61 % EBIT million

More information

AUSTRIAN POST Q1 2012:

AUSTRIAN POST Q1 2012: AUSTRIAN POST Q1 2012: Revenue growth (+6.0%) and earnings improvement (EBITDA +7.0%) in Q1; outlook confirmed for 2012 Increased revenue Revenue up 6.0% above the prior-year quarter Good development in

More information

Unaudited Nine Months Financial Report

Unaudited Nine Months Financial Report RECRUITING SERVICES Amadeus FiRe AG Unaudited Nine Months Financial Report January to September 2015 Temporary Staffing. Permanent Placement Interim Management. Training www.amadeus-fire.de Unaudited Nine

More information

Logwin AG. Interim Financial Report as of 31 March 2015

Logwin AG. Interim Financial Report as of 31 March 2015 Logwin AG Interim Financial Report as of 31 March 2015 Key Figures 1 January 31 March 2015 Earnings position In thousand EUR 2015 2014 Revenues Group 274,433 278,533 Change on 2014-1.5% Solutions 101,821

More information

Travel24.com AG. Quarterly Report Q1 2015

Travel24.com AG. Quarterly Report Q1 2015 Travel24.com AG Quarterly Report Q1 2015 2 Selected Key Group Data January 1 - March 31 Change In thousands of euro 2015 2014 % Revenue 4,494 7,810-42 % EBIT 806 1,231-35 % Net profit 66 518-87 % Earnings

More information

Unaudited Financial Report

Unaudited Financial Report RECRUITING SERVICES Amadeus FiRe AG Unaudited Financial Report Quarter I - 2015 Temporary Staffing. Permanent Placement Interim Management. Training www.amadeus-fire.de Unaudited Amadeus FiRe Group Financial

More information

Interim Report HORNBACH HOLDING AG GROUP. 1st QUARTER 2004/2005 (March 1 to May 31, 2004)

Interim Report HORNBACH HOLDING AG GROUP. 1st QUARTER 2004/2005 (March 1 to May 31, 2004) Interim Report HORNBACH HOLDING AG GROUP 1st QUARTER 2004/2005 (March 1 to May 31, 2004) page 2 HORNBACH HOLDING AG Group Interim Report (IFRS) for the First Quarter of 2004/2005 (March 1 to May 31, 2004)

More information

nine months statement

nine months statement nine months statement 22 Brüder Mannesmann Aktiengesellschaft Remscheid Brüder Mannesmann AG is a trading group with two orientations the worldwide trading in tools and the trading in pipe fittings for

More information

Quarter Report 2014 ESSANELLE HAIR GROUP AG

Quarter Report 2014 ESSANELLE HAIR GROUP AG Quarter Report 2014 ESSANELLE HAIR GROUP AG Q1 2 Q1/2014 ESSANELLE HAIR GROUP KEY FIGURES for 1 January to 31 March 2014/2013 (IFRS) million 2014 2013 Change* Consolidated sales 32.3 30.8 +4.7% essanelle

More information

Letter from the Management Board 3. Key Financial Figures 4. Management Report 5. Consolidated Statements of Operations (IFRS) 9

Letter from the Management Board 3. Key Financial Figures 4. Management Report 5. Consolidated Statements of Operations (IFRS) 9 9-Months Report 2014 Content Letter from the Management Board 3 Key Financial Figures 4 Management Report 5 Consolidated Statements of Operations (IFRS) 9 Consolidated Statement of Comprehensive Income

More information

Ahlers AG, Herford. ISIN DE0005009708 and DE0005009732 INTERIM REPORT

Ahlers AG, Herford. ISIN DE0005009708 and DE0005009732 INTERIM REPORT Ahlers AG, Herford ISIN DE0005009708 and DE0005009732 on the first nine months of fiscal 2005/06 (December 1, 2005, to August 31, 2006) BUSINESS DEVELOPMENT IN THE FIRST NINE MONTHS OF FISCAL 2005/06 According

More information

9-MONTHS REPORT. Stable development of business in Q3 Lila Logistik confirms full-year forecast

9-MONTHS REPORT. Stable development of business in Q3 Lila Logistik confirms full-year forecast /08 9-MONTHS REPORT Stable development of business in Q3 Lila Logistik confirms full-year forecast Key figures for the first three quarters of 2008 in accordance with IFRS 01.01. 01.01. Change in Change

More information

INTERIM REPORT ON FIRST QUARTER OF 2015 201fehlungBild austauschen) Q1

INTERIM REPORT ON FIRST QUARTER OF 2015 201fehlungBild austauschen) Q1 Interim Report Q1 2015 INTERIM REPORT ON FIRST QUARTER OF 2015 201fehlungBild austauschen) Q1 1 Interim Report Q1 2015 2 Letter from the Management Board Dear Shareholders, Ladies and Gentlemen, These

More information

TO OUR SHAREHOLDERS PROFITABLE GROWTH COURSE INTERNATIONALIZATION FURTHER EXTENDED US MARKET IN FOCUS

TO OUR SHAREHOLDERS PROFITABLE GROWTH COURSE INTERNATIONALIZATION FURTHER EXTENDED US MARKET IN FOCUS QUARTERLY STATEMENT AS OF MARCH 31, 2015 TO OUR SHAREHOLDERS Patrik Heider, Spokesman of the Executive Board and CFOO The Nemetschek Group has made a dynamic start in the 2015 financial year and continues

More information

Quarterly Report II/2004

Quarterly Report II/2004 Quarterly Report II/ Foreword Group management report Dear Shareholders, Result of operations Stagnating share prices and declining trading volumes dominated the German stock exchanges in Q2. The hike

More information

Consolidated Interim Report

Consolidated Interim Report Consolidated Interim Report as of 31 March 2015 UNIWHEELS AG CONTENTS 1. Key performance data 2. Condensed group management report as of 31 March 2015 3. Condensed consolidated financial statements as

More information

Ahlers AG, Herford. ISIN DE0005009708 and DE0005009732 INTERIM REPORT

Ahlers AG, Herford. ISIN DE0005009708 and DE0005009732 INTERIM REPORT Ahlers AG, Herford ISIN DE0005009708 and DE0005009732 I N T E R I M R E P O R T for the first six months of the 2006/07 financial year (December 1, 2006 to May 31, 2007) BUSINESS DEVELOPMENT IN THE FIRST

More information

Interim report as at 30 September 2015

Interim report as at 30 September 2015 Interim report as at 30 September 2015 Fielmann improves unit sales, revenue and profit Specialists of tomorrow: 3,000 apprentices Fielmann creates 500 new jobs Fielmann Aktiengesellschaft Group interim

More information

Quarterly Financial Report March 31, 2009. MBB Industries AG. Berlin

Quarterly Financial Report March 31, 2009. MBB Industries AG. Berlin Quarterly Financial Report March 31, 2009 MBB Industries AG. Berlin Quarterly Financial Report March 31, 2009 MBB Industries AG MBB Industries in Numbers 03 MBB Industries in Numbers Three Month (Jan.

More information

2014/2015 The IndusTrIal Group

2014/2015 The IndusTrIal Group Q2 2014/2015 Half-Year Interim Report 2014/2015 1 April to 30 September 2014 The Industrial Group The first six months of financial year 2014/2015 at a glance Incoming orders increased in the first half

More information

! "#$ %&!& "& ' - 3+4 &*!&-.,,5///2!(.//+ & $!- )!* & % +, -).//0)& 7+00///2 *&&.4 &*!&- 7.00///2 )!*.//+ 8 -!% %& "#$ ) &!&.

! #$ %&!& & ' - 3+4 &*!&-.,,5///2!(.//+ & $!- )!* & % +, -).//0)& 7+00///2 *&&.4 &*!&- 7.00///2 )!*.//+ 8 -!% %& #$ ) &!&. ! "#!""#$%$#$#$"& $'"()*+,$-).,/ 012! "#$ %&!& "& '!(&)!*&%+,-).//0 -#$#3-4' &,'1$1# $!-!(.//0)& +01+///2 *&& - 3+4 &*!&-.,,5///2!(.//+ &!(!-6%(!(.//.$(!(.//0)& 01,///2 //+2% &*!&- 5,0///2 //32%!(.//+

More information

CENIT AG Systemhaus. Industriestraße 52-54 D-70565 Stuttgart Tel: + 49 711 7825-30 Fax: + 49 711 7825-4000 Internet: http://www.cenit.

CENIT AG Systemhaus. Industriestraße 52-54 D-70565 Stuttgart Tel: + 49 711 7825-30 Fax: + 49 711 7825-4000 Internet: http://www.cenit. 9 Months Report 2007 CENIT AG Systemhaus Industriestraße 52-54 D-70565 Stuttgart Tel: + 49 711 7825-30 Fax: + 49 711 7825-4000 Internet: http://www.cenit.de Investor Relations: ISIN:DE0005407100 Fabian

More information

Interim report as at 31 March 2014. Unit sales, revenue and profit increase Dividend increases to 2.90 per share Stock split ratio of two-for-one

Interim report as at 31 March 2014. Unit sales, revenue and profit increase Dividend increases to 2.90 per share Stock split ratio of two-for-one Interim report as at 31 March 2014 Unit sales, revenue and profit increase Dividend increases to 2.90 per share Stock split ratio of two-for-one Fielmann Aktiengesellschaft Group interim report as at 31

More information

Logwin AG. Interim Financial Report as of 30 September 2015

Logwin AG. Interim Financial Report as of 30 September 2015 Logwin AG Interim Financial Report as of 30 September 2015 Key Figures 1 January 30 September 2015 Earnings position In thousand EUR 2015 2014 Revenues Group 805,065 842,390 Change on 2014-4.4% Solutions

More information

Q1- Celesio ag Interim Report 1st 3rd Quarter of 2012. revenue and earnings above previous year. stabilisation begins to deliver results

Q1- Celesio ag Interim Report 1st 3rd Quarter of 2012. revenue and earnings above previous year. stabilisation begins to deliver results Celesio ag Interim Report 1st 3rd Quarter of 2012 Q1- revenue and earnings above previous year stabilisation begins to deliver results positive results from the operational excellence program already seen

More information

Interim report as at 31 March 2015

Interim report as at 31 March 2015 Interim report as at 31 March 2015 Increase of unit sales, revenue and profit Dividend raises to 1.60 per share Fielmann expects continuation of positive business performance Fielmann Aktiengesellschaft

More information

Group 9-month report Bastei Lübbe AG 1 Apr - 31 Dec 2015

Group 9-month report Bastei Lübbe AG 1 Apr - 31 Dec 2015 Group 9-month report Bastei Lübbe AG 1 Apr - 31 Dec 2015 At a Glance Key figures (IFRS) 01/04/2015-2015 01/04/- Change in % Business development in million Group turnover 79.4 86.8-8.5 % EBITDA 14.0 11.5

More information

Logwin AG. Nine-Month Financial Report 2014

Logwin AG. Nine-Month Financial Report 2014 Logwin AG Nine-Month Financial Report 2014 Key Figures 1 January 30 September 2014 Earnings position In thousand EUR 2014 2013 Revenues Group 842,390 932,384 Change on 2013-9.7 % Solutions 366,604 470,658

More information

Interim report as at 30 September 2014

Interim report as at 30 September 2014 Interim report as at 30 September 2014 Fielmann increases unit sales, revenue and profit Result registers significant growth in the 3 rd quarter of 2014 Fielmann trains more than 2,900 opticians Fielmann

More information

Consolidated Half-Year Report of Baader Bank AG as at 30.06.2014

Consolidated Half-Year Report of Baader Bank AG as at 30.06.2014 Consolidated Half-Year Report of Baader Bank AG as at 30.06.2014 OVERVIEW OF KEY FIGURES RESULTS OF OPERATIONS 01.01-30.06.2014 01.01-30.06.2013 Change in % Net interest income thousand 1,017 1,991-48.9

More information

Unaudited Half Year Financial Report January June 2013. Creating career prospects and deploying targeted professional skills.

Unaudited Half Year Financial Report January June 2013. Creating career prospects and deploying targeted professional skills. Creating career prospects and deploying targeted professional skills Amadeus FiRe AG Unaudited Half Year Financial Report January June 2013 Unaudited Half Year Financial Report, January June 2013 1 Unaudited

More information

TO OUR SHAREHOLDERS DYNAMIC FIRST HALF YEAR

TO OUR SHAREHOLDERS DYNAMIC FIRST HALF YEAR HALF YEAR REPORT AS OF JUNE 30, 2015 TO OUR SHAREHOLDERS Patrik Heider, Spokesman of the Executive Board and CFOO The Nemetschek Group maintained its dynamic development from the first quarter of 2015

More information

3-month report January - March 2007 Published on August 10, 2007

3-month report January - March 2007 Published on August 10, 2007 3-month report January - March 2007 Published on August 10, 2007 3-month report January March 2007 1. Group management report for the first quarter of 2007 Overview of the first quarter in 2007 Continued

More information

3 MONTH REPORT AS AT 31 DECEMBER 2014

3 MONTH REPORT AS AT 31 DECEMBER 2014 3 MONTH REPORT AS AT 31 DECEMBER 2014 KEY FIGURES IFRS in KEUR 10/2014 12/2014 10/2013 12/2013 Difference in % Earnings situation Sales revenues 61,403 56,296 5,107 9% EBITDA 7,159 5,901 1,258 21% EBITDA

More information

Reporting and Analyzing Cash Flows QUESTIONS

Reporting and Analyzing Cash Flows QUESTIONS Chapter 12 Reporting and Analyzing Cash Flows QUESTIONS 1. The purpose of the cash flow statement is to report all major cash receipts (inflows) and cash payments (outflows) during a period. It helps users

More information

DEUFOL SE JOHANNES-GUTENBERG-STR. 3 5 65719 HOFHEIM (WALLAU), GERMANY PHONE: + 49 (61 22) 50-00 FAX: + 49 (61 22) 50-13 00 WWW.

DEUFOL SE JOHANNES-GUTENBERG-STR. 3 5 65719 HOFHEIM (WALLAU), GERMANY PHONE: + 49 (61 22) 50-00 FAX: + 49 (61 22) 50-13 00 WWW. SEMI-ANNUAL REPORT 5 Key Figures for the Deufol Group figures in thousand 6M 2015 6M 2014 Results of operations Revenue (total) 152,088 141,450 Germany 83,770 77,730 Rest of the World 68,318 63,720 International

More information

Interim Report 201. Celesio AG. report as of 30 September 2015

Interim Report 201. Celesio AG. report as of 30 September 2015 Interim Report 201 Celesio AG H1 Half-year financial report as of 30 September 2015 The Celesio Group Celesio is a leading international wholesale and retail company and provider of logistics and services

More information

HALF YEAR REPORT AS OF JUNE 30

HALF YEAR REPORT AS OF JUNE 30 2 0 1 4 HALF YEAR REPORT AS OF JUNE 30 T O O U R S H A R E H O L D E R S Dear shareholders, ladies and gentlemen, The Nemetschek Group continued its successful development in the second quarter of 2014

More information

Logwin AG. Interim Financial Report as of 30 June 2015

Logwin AG. Interim Financial Report as of 30 June 2015 Logwin AG Interim Financial Report as of 30 June 2015 Key Figures 1 January 30 June 2015 Earnings position In thousand EUR 2015 2014 Revenues Group 532,027 543,168 Change on 2014-2.1% Solutions 190,467

More information

Contact 6-Month Report 2005

Contact 6-Month Report 2005 Contact 6-Month Report 2005 Security Networks AG Kronprinzenstrasse 30 45128 ssen Germany Phone: +49 (0) 201 54 54-0 Fax: +49 (0) 201 54 54-456 Internet: www..com -mail: investor.relations@.com Key figures

More information

FINANCIAL REPORT H1 2014

FINANCIAL REPORT H1 2014 FINANCIAL REPORT H1 2014 HIGH SPEED BY PASSION 02_Key Figures 03_Group Status Report 05_Consolidated Financial Statements 10_Notes 11_Declaration of the Legal Representatives 02 PANKL KEY FIGURES EARNING

More information

STADA KEY FIGURES. 02 STADA Key Figures. 9 months 2013 Jan. 1 Sep. 30 1) ± % 9 months 2014 Jan. 1 Sep. 30. Key figures for the Group in million

STADA KEY FIGURES. 02 STADA Key Figures. 9 months 2013 Jan. 1 Sep. 30 1) ± % 9 months 2014 Jan. 1 Sep. 30. Key figures for the Group in million 02 STADA Key Figures STADA KEY FIGURES Key figures for the Group in million 9 months 2014 Jan. 1 Sep. 30 9 months 2013 Jan. 1 Sep. 30 1) ± % Group sales 1,482.7 1,426.2 +4% Generics (core segment) 884.2

More information

2014 Quarterly Report II

2014 Quarterly Report II 2014 Quarterly Report II 2 Key data Eckert & Ziegler 01 06/2014 01 06/2013 Change Sales million 61.9 55.3 12% Return on revenue before tax % 9 % 12 % 26 % EBITDA million 9.7 10.2 5 % EBIT million 6.2 6.9

More information

GULF PHARMACEUTICAL INDUSTRIES (A PUBLIC SHAREHOLDING COMPANY) RAS AL KHAIMAH - UNITED ARAB EMIRATES

GULF PHARMACEUTICAL INDUSTRIES (A PUBLIC SHAREHOLDING COMPANY) RAS AL KHAIMAH - UNITED ARAB EMIRATES GULF PHARMACEUTICAL INDUSTRIES (A PUBLIC SHAREHOLDING COMPANY) RAS AL KHAIMAH - UNITED ARAB EMIRATES CONSOLIDATED INTERIM FINANCIAL INFORMATION AND REVIEW REPORT FOR THE SIX MONTH PERIOD ENDED JUNE 30,

More information

Liquidity and Funding Resources

Liquidity and Funding Resources 112 Allianz Group Annual Report Liquidity and Funding Resources Organization The liquidity management of the Allianz Group is based on policies and guidelines approved by the Board of Management of Allianz

More information

RHÖN-KLINIKUM AG. Interim Report First Quarter 2007

RHÖN-KLINIKUM AG. Interim Report First Quarter 2007 RHÖN-KLINIKUM AG Interim Report First Quarter 2007 Interim report to our shareholders for the first quarter of 2007 General remarks We are pleased to present this interim report which has been prepared

More information

Consolidated Nine-month Report of Baader Bank AG as of 30 September 2012

Consolidated Nine-month Report of Baader Bank AG as of 30 September 2012 Consolidated Nine-month Report of Baader Bank AG as of 30 September 2012 Overview of key figures EARNINGS 1 Jan. - 30 Sept. 2012 1 Jan. - 30 Sept. 2011 Change % Net interest income thou. 4.06 4.66-13.0

More information

Significant Accounting Policies

Significant Accounting Policies Apart from the accounting policies presented within the corresponding notes to the financial statements, other significant accounting policies are set out below. These policies have been consistently applied

More information

VASSETI (UK) PLC CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED 30 JUNE 2013

VASSETI (UK) PLC CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED 30 JUNE 2013 CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED 30 JUNE 2013 INTERIM MANAGEMENT REPORT (UNAUDITED) FOR THE 6 MONTHS ENDED 30 JUNE 2013 1. Key Risks and uncertainties Risks and uncertainties

More information

Company Presentation Conference Call Q1 2005, May 13 REpower Systems AG

Company Presentation Conference Call Q1 2005, May 13 REpower Systems AG Company Presentation Conference Call Q1 2005, May 13 REpower Systems AG Speakers today Prof. Dr. Fritz Vahrenholt Pieter Wasmuth CEO & Corporate Strategy Finance & Personnel Former member of the board

More information

Quarterly Financial Report. as of March 31, 2010. Qarterly Financial Report. as of March 31, 2010

Quarterly Financial Report. as of March 31, 2010. Qarterly Financial Report. as of March 31, 2010 Quarterly Financial Report as of March 31, 2010 Qarterly Financial Report as of March 31, 2010 PULSION Quarterly Financial Report as at March 31, 2010 1 PULSION at a glance PULSION (Group) according to

More information

Report on the nine-month period ended July 31, 2004 WKN: 330 410 ISIN: DE0003304101

Report on the nine-month period ended July 31, 2004 WKN: 330 410 ISIN: DE0003304101 GERRY WEBER International AG Report on the first nine months of 2003/2004 Report on the nine-month period ended July 31, 2004 WKN: 330 410 ISIN: DE0003304101 The GERRY WEBER share: While the stock market

More information

Dear shareholders and business partners,

Dear shareholders and business partners, Quarterly Report 2015 bmp Quarterly Report 2015 Foreword Jens Spyrka Oliver Borrmann Dear shareholders and business partners, The year 2015 will bring major changes for bmp media investors AG. After lengthy

More information

For personal use only

For personal use only General Purpose Financial Statements For the Half-Year Ended 31 December 2013 Financial Statements CONTENTS Pages Directors Report 2 Auditor s Independence Declaration 4 Independent Review Report 5 Directors

More information

APPENDIX 4E ANNUAL REPORT THORN GROUP LIMITED ACN 072 507 147 YEAR ENDED 31 MARCH 2015. Page 1 of 7

APPENDIX 4E ANNUAL REPORT THORN GROUP LIMITED ACN 072 507 147 YEAR ENDED 31 MARCH 2015. Page 1 of 7 APPENDIX 4E ANNUAL REPORT THORN GROUP LIMITED ACN 072 507 147 YEAR ENDED 31 MARCH 2015 1 Details of the reporting period and the previous corresponding period Current period: 1 April 2014 to 31 March 2015

More information

Financial Report 9M 2014

Financial Report 9M 2014 Financial Report 9M 2014 1 von 10 12.11.14 13:19 1. Financial Summary Income (in TEUR) 9M 2014 9M 2013 Revenues 9,485 9,992 Software & Subscriptions 8,668 8,127 Services 817 1,865 EBIT 2,926 1,051 as a

More information

TIPTEL AG. Interim report of the TIPTEL Group. for the period from January 1 to September 30, 2006. tiptel

TIPTEL AG. Interim report of the TIPTEL Group. for the period from January 1 to September 30, 2006. tiptel TIPTEL AG Interim report of the TIPTEL Group for the period from January 1 to September 30, 2006 tiptel Letter to the Shareholders Dear shareholders and business friends, By September 30, 2006 our turnover

More information

InVision AG Workforce Management Cloud Services Call Center Training. Financial Report 9M 2014

InVision AG Workforce Management Cloud Services Call Center Training. Financial Report 9M 2014 Financial Report 9M 2014 Seite 1 von 7 1. Financial Summary Income (in TEUR) 9M 2014 9M 2013 Revenues 9,485 9,992-5% Software & Subscriptions 8,668 8,127 +7% Services 817 1,865-56% EBIT 2,926 1,051 +178%

More information

Capcon Holdings plc. Interim Report 2011. Unaudited interim results for the six months ended 31 March 2011

Capcon Holdings plc. Interim Report 2011. Unaudited interim results for the six months ended 31 March 2011 Capcon Holdings plc Interim Report 2011 Unaudited interim results for the six months ended 31 March 2011 Capcon Holdings plc ("Capcon" or the "Group"), the AIM listed investigations and risk management

More information

Big Yellow Group PLC Interim 2003

Big Yellow Group PLC Interim 2003 Big Yellow Group PLC Interim 2003 CONTENTS ifc Financial Highlights 01 Trading Summary 02 Chairman s Statement 04 Consolidated Profit and Loss Account 05 Consolidated Balance Sheet 06 Reconciliation of

More information

Half Year Report 2009

Half Year Report 2009 Half Year Report 2009 Oliver Borrmann Andreas van Bon Ralph Günther Dear shareholders and business partners, The second quarter of 2009 failed to bring an upturn in our business of venture capital direct

More information

Key figures as of June 30, 2013 1st half

Key figures as of June 30, 2013 1st half Never standing still. Interim Report as of June 30, 2013 Contents 2 Key figures as of June 30, 2013 1st half 3 Key figures as of June 30, 2013 2nd quarter 6 Strong revenue growth 12 Consolidated interim

More information

2015 Results and Prospects

2015 Results and Prospects PRESS RELEASE Paris, 23 March 2016 2015 Results and Prospects Revenues: 2,579.3 million, up 3.2% EBITDA: 342.0 million, an operating margin of 13.3% 2016 Objectives: revenues close to 3 billion and an

More information

Restated Consolidated Financial Statements as at December 31, 2011

Restated Consolidated Financial Statements as at December 31, 2011 Restated Consolidated Financial Statements as at December 31, 2011 (including the adjusted adidas AG Opening Consolidated Statement of Financial Position (IFRS) as at January 1, 2011) This excerpt from

More information

Consolidated Financial Statements for the Third Quarter of the Fiscal Year Ending March 31, 2008

Consolidated Financial Statements for the Third Quarter of the Fiscal Year Ending March 31, 2008 February 5, 2008 Consolidated Financial Statements for the Third Quarter of the Fiscal Year Ending March 31, 2008 Corporate Name: Alfresa Holdings Corporation (Code: 2784, 1st sections of Tokyo Stock Exchange

More information

Employees Employees as at 31 August 53 44 20.5 Employees average during the reporting period 52 44 18.2

Employees Employees as at 31 August 53 44 20.5 Employees average during the reporting period 52 44 18.2 9M 2007 9M 2006 Change in % Earnings key figures in EUR 000 Other operating income 2,158 966 123.4 Operating expenses (19,486) (13,149) 48.2 of which research and development (16,606) (10,527) 57.8 Operating

More information

JOHN WILEY & SONS, INC. UNAUDITED SUMMARY OF OPERATIONS FOR THE FIRST QUARTER ENDED JULY 31, 2011 AND 2010 (in thousands, except per share amounts)

JOHN WILEY & SONS, INC. UNAUDITED SUMMARY OF OPERATIONS FOR THE FIRST QUARTER ENDED JULY 31, 2011 AND 2010 (in thousands, except per share amounts) UNAUDITED SUMMARY OF OPERATIONS FOR THE FIRST QUARTER ENDED JULY 31, 2011 AND 2010 (in thousands, except per share amounts) US GAAP First Quarter Ended Revenue $ 430,069 407,938 5% Costs and Expenses Cost

More information

Financial Statements Tutorial

Financial Statements Tutorial Financial Statement Review: Financial Statements Tutorial There are four major financial statements used to communicate information to external users (creditors, investors, suppliers, etc.) - 1. Balance

More information

NedSense enterprises n.v. Condensed consolidated Interim financial statements

NedSense enterprises n.v. Condensed consolidated Interim financial statements NED NEDSENSE enterprises n.v. NedSense enterprises n.v. Condensed consolidated Interim financial statements 30 June 2012 NedSense enterprises n.v. Half-year Report 2012 (unaudited) Report of the Board

More information

I D E A S M E A N D Y N A M I C F O R C E

I D E A S M E A N D Y N A M I C F O R C E I D E A S M E A N D Y N A M I C F O R C E INTERIM REPORT I/27 D Y N A M I C F O R C E M E A N S P R O G R E S S KEY FIGURES (HGB) Group 31/3/27 31/3/26 Revenue EUR millions 2.4 17.6 Foreign share % 68.1

More information

Interim Report 2002/3

Interim Report 2002/3 Interim Report 2002/3 Highlights Financial results Turnover increased by 42% to 111.7m (2001: 78.6m) Profit before tax, goodwill and exceptional item increased by 2% to 15.3m (2001: 15.1m) Earnings per

More information

AssetCo plc ( AssetCo or the Company ) Results for the six-month period ended 31 March 2012

AssetCo plc ( AssetCo or the Company ) Results for the six-month period ended 31 March 2012 Issued on behalf of AssetCo plc Date: Friday 29 June 2012 Immediate Release Statement by the Chairman, Tudor Davies AssetCo plc ( AssetCo or the Company ) Results for the six-month period ended 31 March

More information

BMW Group Corporate and Governmental Affairs

BMW Group Corporate and Governmental Affairs BMW Group Corporate and Governmental Affairs Media Information 18 March 2009 - Check against delivery - Statement by Dr. Friedrich Eichiner Member of the Board of Management of BMW AG, Finance Annual Accounts

More information

Financial results for the six months ended 30 June 2007

Financial results for the six months ended 30 June 2007 13 August 2007 Fleet Place House 2 Fleet Place, Holborn Viaduct London EC4M 7RF Tel: +44 (0)20 7710 5000 Fax: +44 (0)20 7710 5001 www.mcgplc.com Financial results for the six months 2007 Management Consulting

More information

Kabel Deutschland continues to post strong growth

Kabel Deutschland continues to post strong growth INVESTOR RELATIONS RELEASE Kabel Deutschland continues to post strong growth Unterfoehring, November 17, 2009 Kabel Deutschland (KDG), Germany s largest cable operator, announced today its financial results

More information

Interim financial report third quarter 2014 Investor presentation. Koen Van Gerven, CEO Pierre Winand, CFO

Interim financial report third quarter 2014 Investor presentation. Koen Van Gerven, CEO Pierre Winand, CFO Interim financial report third quarter 204 Investor presentation Koen Van Gerven, CEO Pierre Winand, CFO Brussels November, 4th 204 Investor presentation - Interim financial report 3Q4 2 Financial Calendar

More information

MASTER BUDGET - EXAMPLE

MASTER BUDGET - EXAMPLE MASTER BUDGET - EXAMPLE Sales IN UNITS for the previous two months (of last quarter), as well as the sales forecast for next quarter are as follows: Sales Budget Units May sales (ACTUAL) 20 June sales

More information

Overview of the key figures for the first nine months

Overview of the key figures for the first nine months Continued revenue growth: up 12% on previous year Results impacted by revenue structure and one-off effects High volume of orders: outlook remains optimistic Q3 Overview of the key figures for the first

More information

BREMER LAGERHAUS-GESELLSCHAFT Aktiengesellschaft von Interim Report

BREMER LAGERHAUS-GESELLSCHAFT Aktiengesellschaft von Interim Report BREMER LAGERHAUS-GESELLSCHAFT Aktiengesellschaft von 1877 Interim Report January to March 2014 Table of contents 03 BLG share 05 Management Report for the Interim Financial Statments 05 Basic features

More information

Transition to International Financial Reporting Standards

Transition to International Financial Reporting Standards Transition to International Financial Reporting Standards Topps Tiles Plc In accordance with IFRS 1, First-time adoption of International Financial Reporting Standards ( IFRS ), Topps Tiles Plc, ( Topps

More information

www.deutsche-wohnen.de

www.deutsche-wohnen.de JANUARY 1 TO JUNE 30, 2003 INTERIM REPORT www.deutsche-wohnen.de EUR 159.00 High: EUR 159.00 (June 26, 2003) 158.00 157.00 156.00 155.00 154.00 153.00 152.00 151.00 150.00 149.00 148.00 147.00 146.00 145.00

More information

1. Operating, Investment and Financial Cash Flows

1. Operating, Investment and Financial Cash Flows 1. Operating, Investment and Financial Cash Flows Solutions Problem 1 During 2005, Myears Oil Co. had gross sales of $1 000,000, cost of goods sold of $400,000, and general and selling expenses of $300,000.

More information

Roche Capital Market Ltd Financial Statements 2009

Roche Capital Market Ltd Financial Statements 2009 R Roche Capital Market Ltd Financial Statements 2009 1 Roche Capital Market Ltd, Financial Statements Reference numbers indicate corresponding Notes to the Financial Statements. Roche Capital Market Ltd,

More information

Interim Consolidated Financial Statements (Unaudited)

Interim Consolidated Financial Statements (Unaudited) Interim Consolidated Financial Statements (Unaudited) For the Six Months Ended, NTT FINANCE CORPORATION This document has been translated and reclassified from a part of the Japanese

More information

Dear shareholders, TAKKT highlights during the first six months of 2001. The TAKKT group. Half-year report 2001

Dear shareholders, TAKKT highlights during the first six months of 2001. The TAKKT group. Half-year report 2001 Half-year report 2001 Stuttgart, July 2001 Dear shareholders, TAKKT AG continued its dynamic development during the first six months of 2001. Compared to the same period last year, the group increased

More information

GERRY WEBER International AG Report on the first three months of 2005/2006 Report on the three-month period ended January 31, 2006 ISIN: DE0003304101

GERRY WEBER International AG Report on the first three months of 2005/2006 Report on the three-month period ended January 31, 2006 ISIN: DE0003304101 GERRY WEBER International AG Report on the first three months of 2005/2006 Report on the three-month period ended January 31, 2006 ISIN: DE0003304101 The GERRY WEBER share Building on its excellent price

More information

Consolidated Quarterly Report of Baader Bank AG as at 31.03.2015

Consolidated Quarterly Report of Baader Bank AG as at 31.03.2015 Consolidated Quarterly Report of Baader Bank AG as at 31.03.2015 OVERVIEW OF KEY FIGURES RESULTS OF OPERATIONS Q1 2015 Q1 2014 Change in % Net interest income EUR thousand -95 869 >-100.0 Current income

More information

ACER INCORPORATED AND SUBSIDIARIES. Consolidated Balance Sheets

ACER INCORPORATED AND SUBSIDIARIES. Consolidated Balance Sheets Consolidated Balance Sheets June 30, 2015, December 31, 2014, and (June 30, 2015 and 2014 are reviewed, not audited) Assets 2015.6.30 2014.12.31 2014.6.30 Current assets: Cash and cash equivalents $ 36,400,657

More information

Financial Statement Analysis: An Introduction

Financial Statement Analysis: An Introduction Financial Statement Analysis: An Introduction 2014 Level I Financial Reporting and Analysis IFT Notes for the CFA exam Contents 1. Introduction... 3 2. Scope of Financial Statement Analysis... 3 3. Major

More information

FIRST HALF-YEAR RESULTS 2005/2006

FIRST HALF-YEAR RESULTS 2005/2006 P R E S S R E L E A S E FIRST HALF-YEAR RESULTS 2005/2006 Baarn, 1 November 2005, before start of trading Main points from half-year figures for 2005/2006: Group turnover rose by 5% in the first half year

More information

Interim Report First Quarter of Fiscal 2005

Interim Report First Quarter of Fiscal 2005 s Interim Report First Quarter of Fiscal 2005 Introduction We prepare the Interim Report as an update of our Annual Report, with a focus on the current reporting period. As such, the Interim Report should

More information

how to prepare a cash flow statement

how to prepare a cash flow statement business builder 4 how to prepare a cash flow statement zions business resource center zions business resource center 2 how to prepare a cash flow statement A cash flow statement is important to your business

More information

Interim consolidated financial statements as of September 30, 2007

Interim consolidated financial statements as of September 30, 2007 1 Interim consolidated financial statements as of September 30, 2007 January 1 through September 30, 2007 MeVis Medical Solutions AG laying the foundation for further dynamic growth: Sales plus other operating

More information

Quarterly Financial Report Q1 2008

Quarterly Financial Report Q1 2008 This is a translation of the german Quarterly Financial Report Q1 2008 of Business Media China AG. Please be aware that only the original version is legally binding. Quarterly Financial Report Q1 2008

More information

H1 2013 INTERIM REPORT JANUARY JUNE

H1 2013 INTERIM REPORT JANUARY JUNE H1 2013 INTERIM REPORT JANUARY JUNE 2 Contents GENERAL Business Developments Overview 3 Beiersdorf s Shares 4 INTERIM MANAGEMENT REPORT GROUP Results of Operations Group 5 Results of Operations Business

More information

2014/2015 The IndusTrIal Group

2014/2015 The IndusTrIal Group Q1 2014/2015 Interim Report 1 April to 30 june 2014 The Industrial Group The essentials at a glance in the first quarter Big increase in incoming orders, sales on par with previous year, earnings considerably

More information

Interim Report Period: 01-01-2007 to 30-06-2007

Interim Report Period: 01-01-2007 to 30-06-2007 Interim Report TABLE OF CONTENTS At a glance Key figures 3 Letter by the Management Board 4 Group Management Report 5 Focus on high-margin segments 5 International network a key success factor 6 Development

More information